In conclusion, these findings suggest that Gca deficiency in the myeloid lineage thwarts liver steatosis and inflammation in HFD‐induced and MCD‐induced MASH models. This evidence concerns the gene GCA and metabolic dysfunction-associated steatohepatitis.